Creating a fluorescent “AND” logic gate aptamer platform for identifying exosomes derived from breast cancer subtypes
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries10.3322/caac.21834 ↗
2. Cancer statistics for the year 2020: an overview10.1002/ijc.33588 ↗
3. Cancer burden and trends in China: a review and comparison with Japan and South Korea10.21147/j.issn.1000-9604.2020.02.01 ↗
4. Metabolic-Pathway-Based subtyping of Triple-Negative breast cancer reveals potential therapeutic targets10.1016/j.cmet.2020.10.012 ↗
5. High-throughput quantitative detection of triple-negative breast cancer-associated expressed miRNAs by rolling circle amplification on fluorescence-encoded microspheres10.1016/j.cclet.2023.108141 ↗
6. Recent advancements in DNA nanotechnology-enabled extracellular vesicles detection and diagnosis: a mini review10.1016/j.cclet.2022.107926 ↗
7. Cancer diagnosis: from tumor to liquid biopsy and beyond
8. A review on methods for diagnosis of breast cancer cells and tissues10.1111/cpr.12822 ↗
9. Exosome-based liquid biopsies in cancer: opportunities and challenges10.1016/j.annonc.2021.01.074 ↗
10. Liquid biopsy: current technology and clinical applications10.1186/s13045-022-01351-y ↗
11. Breast cancer diagnosis: imaging techniques and biochemical markers10.1002/jcp.26379 ↗
12. The Roles of exosomal proteins: classification, function, and applications10.3390/ijms24043061 ↗
13. The biology and function of exosomes in cancer10.1172/JCI81135 ↗
14. Exosomes: membrane-associated proteins, challenges and perspectives
15. DNA walker induced “signal on” fluorescence aptasensor strategy for rapid and sensitive detection of extracellular vesicles in gastric cancer10.1016/j.cclet.2024.109930 ↗
16. The ins-and-outs of exosome biogenesis, secretion, and internalization10.1016/j.tcb.2023.06.006 ↗
17. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes10.1038/nbt.1807 ↗
18. Exosomes as a new frontier of cancer liquid biopsy10.1186/s12943-022-01509-9 ↗
19. Exosomes in cancer diagnostics10.3390/cancers9010008 ↗
20. The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer
21. Breast cancer: biology, biomarkers, and treatments10.1016/j.intimp.2020.106535 ↗
22. Immunomagnetic capture and traceless release of native tumor-derived exosomes from human plasma for exploring interaction with recipient cells by aptamer-functionalized nanoflowers10.1016/j.aca.2023.342109 ↗
23. Magneto-Mediated electrochemical sensor for simultaneous analysis of breast cancer exosomal proteins10.1021/acs.analchem.0c00106 ↗
24. Facile fluorescent aptasensor using aggregation-induced emission luminogens for exosomal proteins profiling towards liquid biopsy10.1016/j.bios.2020.112520 ↗
25. Efficient exosome subpopulation isolation and proteomic profiling using a Sub-ExoProfile chip towards cancer diagnosis and treatment10.1039/D2AN01268E ↗
26. “One suction and one extrusion” mode-based wash-free platform for determination of breast cancer cell-derived exosomes10.1007/s00604-023-05898-6 ↗
27. Dual rolling circle amplification-enabled ultrasensitive multiplex detection of exosome biomarkers using electrochemical aptasensors10.1016/j.aca.2022.339762 ↗
28. EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer10.1038/bjc.2013.80 ↗
29. Liquid biopsy in breast cancer: a comprehensive review10.1111/cge.13514 ↗
30. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage10.1016/j.ygyno.2011.04.035 ↗
31. PD-L1 expression in human cancers and its association with clinical outcomes10.2147/OTT.S105862 ↗
32. Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer10.1007/s10549-014-2988-5 ↗
33. PD-L1 expression in triple-negative breast cancer10.1158/2326-6066.CIR-13-0127 ↗
34. One‐step thermophoretic AND gate operation on extracellular vesicles improves diagnosis of prostate cancer10.1002/anie.202207037 ↗